Search filters

List of works by John Chi-Hang Yuen

A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.

scientific article published on 10 July 2012

Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.

scientific article

Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutations.

scientific article published in November 2003

Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.

scientific article published in January 2009

Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay

scientific article published on 13 March 2012

High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.

scientific article

Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease.

scientific article published in January 2007

Prevalence of occult hepatitis B infection in a highly endemic area for chronic hepatitis B: a study of a large blood donor population.

scientific article published on 30 July 2010

Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma ⬇️

scientific article

Serum hepatitis B surface antigen (HBsAg) kinetics in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B.

scientific article published on 4 May 2012

Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome

scientific article published on September 2011

Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.

scientific article published in October 2004

Three Years of Continuous Entecavir Therapy in Treatment-Naïve Chronic Hepatitis B Patients: VIRAL Suppression, Viral Resistance and Clinical Safety

article

Paulina is supported by:

About Paulina

Help